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To determine whether the Beijing genotype of
Mycobacterium tuberculosis is emerging in the
Netherlands, we collected data on 6,829 patients during
1993 to 2000. Six percent had the Beijing genotype. This
genotype was associated with diagnosis in recent years,
young age, nationality, and multidrug resistance. 
T
he Beijing genotype is found frequently in Asia (1–3)
but also in outbreaks of multidrug-resistant tuberculo-
sis (MDRTB) in various parts of the world, including
Cuba, Germany, Russia, and Estonia (4–7). The largest
known epidemic of MDRTB in North America was caused
by the W strain, a variant of the Beijing genotype (8–9). A
recent study showed this strain’s emergence and associa-
tion with drug resistance in Vietnam (10). The Beijing
genotype was also responsible for a recent outbreak of
tuberculosis (TB) on the Canary Islands (11).
The relatively high degree of genetic conservation of
Beijing genotype strains found in a widespread area (12)
suggests a recent dissemination and, hence, selective
advantages associated with this genotype of
Mycobacterium tuberculosis. Recently, Beijing genotype
bacteria were reported to carry mutations in putative muta-
tor genes, which may explain a higher adaptability of these
bacteria under stress conditions such as exposure to the
intracellular environment or anti-TB drugs (13). These
mutations may also be the basis of differential interaction
between Beijing genotype bacteria and the host immune
defense system suggested in a recent study in Indonesia
(14).
In the Netherlands, MDRTB is affecting <1% of new
TB patients, in particular immigrants (15–17). The inci-
dence of the Beijing genotype has not yet been described.
The goal of our study was to determine whether the Beijing
genotype is emerging in the Netherlands and whether this
genotype is associated with multidrug resistance.
The Study
Patient data were obtained from the Netherlands
Tuberculosis Register, which is maintained by the Royal
Netherlands Tuberculosis Association and has been in
place since 1993. Municipal health services, which are
responsible for the followup of all TB patients, send infor-
mation using standardized, precoded forms on all reported
TB cases to the register. The register includes information
on demographic characteristics, case detection, risk
groups, type of disease, treatment, and treatment outcome.
Isolates obtained from all 8,210 culture-positive
patients underwent restriction fragment length polymor-
phism (RFLP)–typing with IS6110 as a probe at the
National Institute of Public Health and the Environment.
The Beijing genotype was defined on the basis of spoligo-
type (no spacers 1–34; at least 4 of spacers 35–43) and a
specific region A insertion (18). Certain IS6110 RFLP-
genotype families (clades 47 and 61) were consistently
found to be Beijing genotype (18). Isolates were assigned
to the Beijing genotype on the basis of the IS6110 RFLP
pattern (18). If any doubt about clade membership existed,
we used spoligotyping for the final allocation.
The RFLP results for the period 1993–2000 were
matched to patient data on the basis of date of birth, postal
area code, and sex, resulting in a perfect match for 5,994
(73%) patients and a near-perfect match for 835 (10%)
patients; overall, 83% of the samples matched (6,829
patients). During this period, the Beijing genotype was
observed in 516 cultures, representing 6% of the 8,210
patients. In the matched dataset, 415 (6%) of 6,829 were of
the Beijing genotype. The number of TB cases attributable
to the Beijing genotype tended to increase over time
(Figure; p>0.05). This tendency was observed both among
Dutch patients (r=0.66, 95% confidence interval [CI]
–0.08 to 0.93) and non-Dutch patients (r=0.59, 95% CI
–0.20 to 0.91) (Figure). While the increase in the number
of cases among immigrants may be associated with an
overall increase of immigrants to the Netherlands during
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Table. Risk factors for the Beijing genotype of Mycobacterium tuberculosis, the Netherlands, 1993–2000  
Odds ratio 
Risk factor  Beijing genotype  Total  %  Crude  Adjusted
b (95% confidence intervals) 
Y of diagnosis 
 1993  23  669  3  1.09  1.08 (1.03 to 1.13) 
 1994  41  941  4                              (per year) 
 1995  56  863  6     
 1996  50  946  5     
 1997  64  872  7     
 1998  58  804  7     
 1999  74  879  8     
 2000  49  855  6     
Sex 
 Male  254  4,135  6  1   
 Female  161  2,694  6  0.97   
Age group 
 <25  120  1,522  8  1  1 
 25–34  123  1,925  6  0.80  0.69 (0.53 to 0.91) 
 35–44  64  1,080  6  0.74  0.60 (0.43 to 0.83) 
 45–54  23  614  4  0.45  0.36 (0.23 to 0.57) 
 55–64  24  493  5  0.60  0.55 (0.35 to 0.88) 
 65–74  40  517  8  0.98  0.78 (0.52 to 1.15) 
 75+  21  678  3  0.37  0.30 (0.18 to 0.50) 
Nationality 
 Netherlands  160  2,825  6  1  1 
 Europe (central and eastern)   20  231  9  1.58  1.27 (0.77 to 2.09) 
 Turkey  3  339  1  0.15  0.12 (0.04 to 0.38) 
 Morocco  19  650  3  0.50  0.41 (0.25 to 0.68) 
 Somalia  21  957  2  0.37  0.27 (0.17 to 0.44) 
 Africa (other)   28  594  5  0.82  0.63 (0.41 to 0.96) 
 Asia  140  786  18  3.61  3.01 (2.32 to 3.91) 
 Other  19  345  6  0.97  0.86 (0.53 to 1.42) 
 Unknown  5  102  5  0.86  0.73 (0.29 to 1.84) 
RFLP clustering
a 
 No  212  3,227  7  1   
 Yes, first case  57  1,052  5  0.81   
 Yes, later case  146  2,550  6  0.86   
Localization 
 Pulmonary  268  4,064  7  1   
 Extrapulmonary  113  2,122  5  0.80   
Pulmonary and extrapulmonary  34  643  5  0.79   
Residing in Netherlands  
<6 months  46  641  7  1   
6–11 mo  12  301  4  0.54   
12–23 mo  28  358  8  1.10   
2–4 y  53  767  7  0.96   
>5 y  122  1,710  7  0.99   
Born in Netherlands  117  2,437  5  0.65   
No information  37  615  6  0.83   
Drug resistance 
Susceptible  332  5,910  6  1   
H only  11  227  5  0.86   
S only  34  358  9  1.76   
Other patterns  26  221  12  2.24   
Multidrug-resistant  9  53  17  3.44   
Unknown  3  60  5  0.88   
Multidrug resistance 
Yes  9  53  17  3.21  2.64 (1.22 to 5.74) 
No  406  6,776  6  1  1 
HIV infection 
Yes  14  294  5  0.76   
No  401  6,535  6  1   
aRFLP, restriction fragment length polymorphism.
 
bAdjusted for year of diagnosis, age, nationality, and multidrug resistance. 
 the study period, the increasing numbers among Dutch
patients likely reflect an increasing incidence rate.
The proportion of TB patients who had the Beijing
genotype was significantly associated in univariate analy-
sis with a later year of diagnosis, young age, nationality
(increased among immigrants from Asia and decreased
among those from Morocco, Turkey, Somalia, and other
African countries, compared with Dutch citizens), and
multidrug resistance (Table). These associations persisted
in multivariate analysis (Table). 
The association between the proportion of TB cases
with the Beijing genotype and age was observed in partic-
ular in Dutch patients (chi squaretrend 15.5; p<0.0001), and
was not clear among non-Dutch patients (chi squaretrend
0.8; p>0.2). Among Dutch patients, the Beijing genotype
was more commonly found in new cases (6%, 133/2,130)
than among retreated cases (4%, 18/498; p<0.05). Among
non-Dutch patients, the Beijing genotype was slightly
more common in retreated cases (8%, 19/229) than in new
cases (6%, 204/3,218); however, this occurrence was not
significant (p>0.2). The incidence pattern by person and
time appears consistent with transmission of the Beijing
genotype from immigrants to the Dutch population (19).
The proportion of TB cases with the Beijing genotype
was not substantially associated with HIV infection, pul-
monary localization, RFLP clustering, or duration of stay
in the Netherlands (Table). The lack of association with
RFLP-clustering suggests that the Beijing genotype is not
spreading more quickly than other M. tuberculosis strains.
Of the nine patients with the Beijing genotype and mul-
tidrug resistance, four were from central and eastern
Europe, three from Asia, one from Africa, and one from
the Netherlands. One of these nine patients was RFLP-
clustered; the other patient in that RFLP cluster had been
diagnosed previously and had isolated isoniazid resistance.
During 1993 to 2000 in the Netherlands, the Beijing
genotype represented 6% of TB cases. The Beijing geno-
type was associated with recent diagnoses, young age (in
particular among Dutch citizens), nationality (Eastern
Europe and Asia), and multidrug resistance. Although the
Beijing genotype was associated with multidrug resist-
ance, the number of MDRTB cases was small. No second-
ary cases were observed with the Beijing genotype and
MDRTB. Of the nine cases of MDRTB, only one case may
have been caused by transmission within the Netherlands
from a case-patient who had isoniazid resistance at the
start of treatment and may have acquired rifampicin resist-
ance during treatment. However, the spread of the Beijing
genotype among young people suggests the possible emer-
gence of multidrug resistance and emphasizes the need for
continued surveillance.
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